Claritev Corp. (CTEV)
23.50
0.00 (0.00%)
USD |
NYSE |
Oct 23, 16:00
23.52
+0.02
(+0.09%)
After-Hours: 20:00
Claritev Enterprise Value : 5.069B for Oct. 23, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 5.069B |
| October 22, 2026 | 5.069B |
| October 21, 2026 | 5.060B |
| October 20, 2026 | 5.050B |
| October 19, 2026 | 5.043B |
| October 16, 2026 | 5.045B |
| October 15, 2026 | 5.075B |
| October 14, 2026 | 5.076B |
| October 13, 2026 | 5.073B |
| October 12, 2026 | 5.083B |
| October 09, 2026 | 5.088B |
| October 08, 2026 | 5.083B |
| October 07, 2026 | 5.095B |
| October 06, 2026 | 5.079B |
| October 05, 2026 | 5.089B |
| October 02, 2026 | 5.073B |
| October 01, 2026 | 5.032B |
| September 30, 2026 | 5.029B |
| September 29, 2026 | 5.037B |
| September 28, 2026 | 5.051B |
| September 25, 2026 | 5.064B |
| September 24, 2026 | 5.066B |
| September 23, 2026 | 5.095B |
| September 22, 2026 | 5.170B |
| September 21, 2026 | 5.206B |
| Date | Value |
|---|---|
| September 18, 2026 | 5.193B |
| September 17, 2026 | 5.208B |
| September 16, 2026 | 5.239B |
| September 15, 2026 | 5.273B |
| September 14, 2026 | 5.288B |
| September 11, 2026 | 5.280B |
| September 10, 2026 | 5.293B |
| September 09, 2026 | 5.285B |
| September 08, 2026 | 5.309B |
| September 04, 2026 | 5.322B |
| September 03, 2026 | 5.333B |
| September 02, 2026 | 5.352B |
| September 01, 2026 | 5.337B |
| August 31, 2026 | 5.345B |
| August 28, 2026 | 5.338B |
| August 27, 2026 | 5.328B |
| August 26, 2026 | 5.307B |
| August 25, 2026 | 5.308B |
| August 24, 2026 | 5.290B |
| August 21, 2026 | 5.302B |
| August 20, 2026 | 5.248B |
| August 19, 2026 | 5.270B |
| August 18, 2026 | 5.274B |
| August 17, 2026 | 5.269B |
| August 14, 2026 | 5.316B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| LataMed AI Corp. | 8.893M |
| SCWorx Corp. | -1.068M |
| Health Catalyst, Inc. | 192.61M |
| GoodRx Holdings, Inc. | 1.447B |
| iSpecimen, Inc. | -2.930M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -59.23M |
| Revenue (Quarterly) | 257.48M |
| Total Expenses (Quarterly) | 316.70M |
| EPS Diluted (Quarterly) | -3.491 |
| Gross Profit Margin (Quarterly) | 30.72% |
| Profit Margin (Quarterly) | -23.00% |
| Earnings Yield | -72.36% |
| Operating Earnings Yield | 10.68% |
| Normalized Earnings Yield | -72.32 |